Breast Health Is More Than Early Detection

The Waiting Period Patients Remember

Each year, thousands of Canadian women do the right thing for their health. They attend screening appointments, pay attention to changes in their bodies, and follow through when additional testing is recommended. Yet for many, the most difficult part of the journey begins after an abnormal finding is detected.

The period between screening and diagnosis can be marked by uncertainty and anxiety. Questions arise quickly: What does this result mean? How long will it take to know more? What are my options? While healthcare teams work diligently to provide answers, the experience can feel overwhelming for patients and their families. And follow-up appointments don’t seem to come quickly enough.

Canada has made important progress in breast health over the past decade, including efforts to expand access to screening and increase public awareness.¹ As more women participate in screening programs, however, we must also pay greater attention to what happens next. This is especially important as breast cancer diagnoses are rising among younger women, including many who may fall outside routine screening programs. Detecting a potential concern is only one step in the continuum of care. Ensuring patients can navigate the path to diagnosis with confidence is equally important.

As healthcare leaders, we often focus on improving clinical outcomes. As important as those outcomes are, the patient experience deserves equal consideration. For someone awaiting a biopsy or pathology result, a delay is not measured in weeks. It is measured in sleepless nights, difficult conversations with loved ones, and uncertainty about the future. This is where information can make a meaningful difference. Without clear and trusted information, many patients are left to search for answers on their own, sometimes through sources that may be incomplete, confusing or inaccurate.

Knowledge does not eliminate anxiety, but it can help patients feel more prepared and empowered. Women who understand what to expect during a breast biopsy are often better equipped to ask informed questions, participate in discussions about their care, and make decisions that reflect their personal circumstances, values, and preferences. Clear, accessible information can help transform a process that feels unfamiliar and intimidating into one that is easier to navigate.

This is why clear, accessible information plays an important role alongside clinical care.

The Canadian Partnership Against Cancer identifies timely diagnosis after an abnormal breast screening result as a key quality indicator, with targets of diagnosis within five weeks when no tissue biopsy is needed and within seven weeks when a tissue biopsy is required.² For patients, that timeline is not only a system measure. It can shape how prepared, supported, and confident they feel while waiting for answers.

Currently, with growing demand and a resource-constrained healthcare system, timely care and access remain at risk. In British Columbia, surgery wait times for breast biopsy indicate that 90% of cases are completed within 8.6 weeks⁴. Ontario similarly reports wait times of 44 days in June 2026 from referral to first clinician appointment for benign breast surgery, and an additional 48 days from decision to surgery, again highlighting an overall pathway wait of 92 days (~13 weeks)⁵.

This highlights the long wait times patients face through their breast cancer screening journey when facing the unknown between screening and diagnosis through waiting for appointments and procedures, creating further anxiety for patients.

Building a Better Path to Diagnosis

Improving access to information is only one part of the solution. Continued efforts to streamline diagnostic pathways and reduce unnecessary delays remain essential. Earlier diagnosis and intervention can improve outcomes for patients while helping healthcare systems use limited resources more effectively.¹ When people receive answers sooner, they can move forward sooner, whether that means peace of mind after a benign result or timely access to treatment when needed.

Breast health outcomes are shaped by many factors, including awareness, screening, diagnosis, treatment, and patient support. Progress and education require collaboration among healthcare providers, policymakers, patient organizations, and industry partners. While each plays a different role, all share a common objective: helping women access timely, high-quality care.

The breast health conversation should not end when an abnormality is found. That is often when patients need the most support. By reducing uncertainty, improving access to information, and continuing to advance patient-centred care pathways, we can help more women move from worry to answers and from answers to action.